查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1854937

全球心肺設備市場成長、規模和趨勢分析（按組件、應用和最終用戶分類）—區域展望、競爭策略和細分市場預測（至2034年）

Global Heart-lung Machine Market Growth, Size, Trends Analysis - By Component, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 269 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，全球心肺設備市場規模將達到 49.9 億美元，複合年成長率為 7.15%。

體外循環機，也稱為心肺體外迴圈（CPB機），是一種用於在心臟直視手術期間暫時替代心臟和肺功能的裝置。該機器將血液從心臟和肺部抽出，進行氧合後再輸回體內，因此可以在心臟停止跳動的情況下進行手術。體外循環機主要由幫浦、氧合器以及各種監控和控制系統組成。幫浦負責將血液循環至全身，而氧合器則負責去除血液中的二氧化碳並提供氧氣。

阻礙因素：儘管全球心肺設備市場受益於許多有利的成長要素，但也存在一些阻礙其擴張的因素。例如，設備及其維護成本高昂，阻礙了其廣泛應用，尤其是在開發中國家。此外，心肺設備的操作和維護需要高水準的專業知識和培訓，這可能會限制其在設施和人員有限的小型醫療機構中的使用。

本報告調查了全球心肺設備市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、按各個細分市場、地區/主要國家進行的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 促進因素、阻礙因素、機會與挑戰分析

第5章 市場變數與展望

  • SWOT分析
  • PESTEL 分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭情勢

  • 製造地、銷售區域和產品類型的分佈
  • 併購、合作、產品發布與協作

7. 全球心肺設備市場（依組件分類）

  • 氧合設備
  • 泵浦
  • 套管
  • 監控系統
  • 熱交換單元
  • 血液儲備
  • 其他

8. 全球心肺設備市場（按應用分類）

  • 冠狀動脈繞道手術（CABG）
  • 心臟瓣膜手術
  • 心臟移植
  • 肺移植
  • 其他

9. 全球心肺設備市場（依最終用戶分類）

  • 醫院
  • 心臟中心
  • 其他

第10章：全球心肺設備市場

  • 全球心肺設備市場規模及市場佔有率

第11章 全球心肺設備市場（按地區分類）

  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亞
    • 其他
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美國
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他

第12章：公司簡介

  • Braile BiomA(C)dica
  • ELITE LIFECARE
  • Getinge
  • Hemovent GmbH
  • LivaNova, Inc
  • Medtronic
  • MERA (Senko Medical Instrument Mfg. Co., Ltd)
  • NIPRO
  • Technowood International Pte. Ltd

第13章 結論

第14章簡稱列表

第15章參考鏈接

簡介目錄
Product Code: MEDE2555

Heart lung Machine Market Introduction and Overview

According to SPER Market Research, 'Global Heart-lung Machine Market Size - By Component, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Heart-lung Machine Market is predicted to reach 4.99 billion by 2034 with a CAGR of 7.15%.

The heart-lung machine, also referred to as the cardiopulmonary bypass (CPB) machine, is a tool used to temporarily replace the heart and lungs during open heart surgery. By removing blood from the heart and lungs, oxygenating it, and then reintroducing it into the body, it enables surgeons to do surgery on a still heart. A pump, an oxygenator, and other monitoring and control systems make up the machine. As the pump circulates blood throughout the body, the oxygenator removes carbon dioxide and adds oxygen to the blood.

Restraints: Despite the favorable factors propelling the global market for heart-lung machines, certain barriers impede its expansion. For example, the high expense of heart-lung machines and their upkeep prevents them from being widely used, especially in developing nations. The use of these devices in smaller healthcare facilities with fewer resources may be restricted due to the complexity of their operation and maintenance, which calls for specialized training.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Component, By Application, By End-User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Braile BiomA(C)dica, ELITE LIFECARE, Getinge, Hemovent GmbH, LivaNova, Inc, Medtronic, MERA (Senko Medical Instrument Mfg. Co, Ltd), NIPRO, Technowood International Pte Ltd.

Global Heart-lung Machine Market Segmentation:

By Component: Based on the Component, Global Heart-lung Machine Market is segmented as; Oxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Blood Reservoir, Others.

By Application: Based on the Application, Global Heart-lung Machine Market is segmented as; Coronary Artery Bypass Grafting (CABG), Heart Valve Surgeries, Heart Transplant, Lung Transplant, Others.

By End-User: Based on the End-User, Global Heart-lung Machine Market is segmented as; Hospitals, Cardiac Centers, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1.Introduction

  • 1.1.Scope of the report
  • 1.2.Market segment analysis

2.Research Methodology

  • 2.1.Research data source
    • 2.1.1.Secondary Data
    • 2.1.2.Primary Data
    • 2.1.3.SPERs internal database
    • 2.1.4.Premium insight from KOLs
  • 2.2.Market size estimation
    • 2.2.1.Top-down and Bottom-up approach
  • 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

  • 4.1.Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1.Drivers
    • 4.1.2.Restraints
    • 4.1.3.Opportunities
    • 4.1.4.Challenges

5.Market variable and outlook

  • 5.1.SWOT Analysis
    • 5.1.1.Strengths
    • 5.1.2.Weaknesses
    • 5.1.3.Opportunities
    • 5.1.4.Threats
  • 5.2.PESTEL Analysis
    • 5.2.1.Political Landscape
    • 5.2.2.Economic Landscape
    • 5.2.3.Social Landscape
    • 5.2.4.Technological Landscape
    • 5.2.5.Environmental Landscape
    • 5.2.6.Legal Landscape
  • 5.3.PORTERs Five Forces
    • 5.3.1.Bargaining power of suppliers
    • 5.3.2.Bargaining power of buyers
    • 5.3.3.Threat of Substitute
    • 5.3.4.Threat of new entrant
    • 5.3.5.Competitive rivalry
  • 5.4.Heat Map Analysis

6.Competitive Landscape

  • 6.1.Global Heart-lung Machine Market Manufacturing Base Distribution, Sales Area, Interface Type
  • 6.2.Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Heart-lung Machine Market

7.Global Heart-lung Machine Market, By Component 2021-2034 (USD Million)

  • 7.1.Oxygenators
  • 7.2.Pumps
  • 7.3.Cannula
  • 7.4.Monitoring Systems
  • 7.5.Heat Exchanger Units
  • 7.6.Blood Reservoir
  • 7.7.Others

8.Global Heart-lung Machine Market, By Application 2021-2034 (USD Million)

  • 8.1.Coronary Artery Bypass Grafting (CABG)
  • 8.2.Heart Valve Surgeries
  • 8.3.Heart Transplant
  • 8.4.Lung Transplant
  • 8.5.Others

9.Global Heart-lung Machine Market, By End-User 2021-2034 (USD Million)

  • 9.1.Hospitals
  • 9.2.Cardiac Centers
  • 9.3.Others

10.Global Heart-lung Machine Market, 2021-2034 (USD Million)

  • 10.1.Global Heart-lung Machine Market Size and Market Share

11.Global Heart-lung Machine Market, By Region, 2021-2034 (USD Million)

  • 11.1.Asia-Pacific
    • 11.1.1.Australia
    • 11.1.2.China
    • 11.1.3.India
    • 11.1.4.Japan
    • 11.1.5.South Korea
    • 11.1.6.Rest of Asia-Pacific
  • 11.2.Europe
    • 11.2.1.France
    • 11.2.2.Germany
    • 11.2.3.Italy
    • 11.2.4.Spain
    • 11.2.5.United Kingdom
    • 11.2.6.Rest of Europe
  • 11.3.Middle East and Africa
    • 11.3.1.Kingdom of Saudi Arabia
    • 11.3.2.United Arab Emirates
    • 11.3.3.Qatar
    • 11.3.4.South Africa
    • 11.3.5.Egypt
    • 11.3.6.Morocco
    • 11.3.7.Nigeria
    • 11.3.8.Rest of Middle-East and Africa
  • 11.4.North America
    • 11.4.1.Canada
    • 11.4.2.Mexico
    • 11.4.3.United States
  • 11.5.Latin America
    • 11.5.1.Argentina
    • 11.5.2.Brazil
    • 11.5.3.Rest of Latin America

12.Company Profile

  • 12.1.Braile BiomA(C)dica
    • 12.1.1.Company details
    • 12.1.2.Financial outlook
    • 12.1.3.Interface summary
    • 12.1.4.Recent developments
  • 12.2.ELITE LIFECARE
    • 12.2.1.Company details
    • 12.2.2.Financial outlook
    • 12.2.3.Interface summary
    • 12.2.4.Recent developments
  • 12.3.Getinge
    • 12.3.1.Company details
    • 12.3.2.Financial outlook
    • 12.3.3.Interface summary
    • 12.3.4.Recent developments
  • 12.4.Hemovent GmbH
    • 12.4.1.Company details
    • 12.4.2.Financial outlook
    • 12.4.3.Interface summary
    • 12.4.4.Recent developments
  • 12.5.LivaNova, Inc
    • 12.5.1.Company details
    • 12.5.2.Financial outlook
    • 12.5.3.Interface summary
    • 12.5.4.Recent developments
  • 12.6.Medtronic
    • 12.6.1.Company details
    • 12.6.2.Financial outlook
    • 12.6.3.Interface summary
    • 12.6.4.Recent developments
  • 12.7.MERA (Senko Medical Instrument Mfg. Co., Ltd)
    • 12.7.1.Company details
    • 12.7.2.Financial outlook
    • 12.7.3.Interface summary
    • 12.7.4.Recent developments
  • 12.8.NIPRO
    • 12.8.1.Company details
    • 12.8.2.Financial outlook
    • 12.8.3.Interface summary
    • 12.8.4.Recent developments
  • 12.9.Technowood International Pte. Ltd
    • 12.9.1.Company details
    • 12.9.2.Financial outlook
    • 12.9.3.Interface summary
    • 12.9.4.Recent developments
    • 12.9.5.Others

13.Conclusion

14.List of Abbreviations

15.Reference Links